We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...

in people with early Parkinson’s disease (PD). The NEULARK trial represents a significant advancement in precision medicine, utilizing a state-of-the-art digital biomarker and patient stratification ...

Randy Newman has been a great exception to this unhappy norm. He has never explicitly identified with any ideological ...

About Alterity Therapeutics Limited Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The ...